Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS)

INR 45.73

(-0.24%)

EBITDA Summary of Biofil Chemicals and Pharmaceuticals Limited

  • Biofil Chemicals and Pharmaceuticals Limited's latest annual EBITDA in 2023 was 12.99 Million INR , down -35.43% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited's latest quarterly EBITDA in 2024 Q1 was 3.08 Million INR , down -9.57% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported an annual EBITDA of 12.64 Million INR in 2022, down -14.63% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported an annual EBITDA of 14.83 Million INR in 2021, down -38.2% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported a quarterly EBITDA of -326 Thousand INR for 2023 Q4, down -114.77% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported a quarterly EBITDA of N/A for 2023 FY, down -35.43% from previous quarter.

Annual EBITDA Chart of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2007)

Historical Annual EBITDA of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2007)

Year EBITDA EBITDA Growth
2023 12.99 Million INR -35.43%
2022 12.64 Million INR -14.63%
2021 14.83 Million INR -38.2%
2020 23.74 Million INR 18.66%
2019 19.73 Million INR 79.76%
2018 11.02 Million INR 8.56%
2017 10.04 Million INR -62.53%
2016 27.58 Million INR 97.22%
2015 13.97 Million INR 15.79%
2014 11.95 Million INR 16.64%
2013 10.2 Million INR -4.71%
2012 10.71 Million INR 141.28%
2011 4.5 Million INR -61.46%
2010 11.7 Million INR 78.55%
2009 6.55 Million INR 566.81%
2008 -2.74 Million INR 48.72%
2007 -2.73 Million INR 0.0%

Peer EBITDA Comparison of Biofil Chemicals and Pharmaceuticals Limited

Name EBITDA EBITDA Difference
Aarey Drugs & Pharmaceuticals Limited 45.16 Million INR 71.226%
Aarti Drugs Limited 3.24 Billion INR 99.6%
Aarti Pharmalabs Limited 3.9 Billion INR 99.668%
Ajanta Pharma Limited 12.56 Billion INR 99.897%
Alembic Limited 1.11 Billion INR 98.836%
Alkem Laboratories Limited 24.19 Billion INR 99.946%
Alembic Pharmaceuticals Limited 9.61 Billion INR 99.865%
AstraZeneca Pharma India Limited 2.35 Billion INR 99.449%
Bal Pharma Limited 345.59 Million INR 96.239%
Bliss GVS Pharma Limited 1.47 Billion INR 99.121%
Brooks Laboratories Limited 41.72 Million INR 68.855%
Bafna Pharmaceuticals Limited 114.58 Million INR 88.658%
Caplin Point Laboratories Limited 6.18 Billion INR 99.79%
Divi's Laboratories Limited 25.43 Billion INR 99.949%
Eris Lifesciences Limited 6.98 Billion INR 99.814%
Granules India Limited 8.6 Billion INR 99.849%
Ind-Swift Limited 1.06 Billion INR 98.78%
Jagsonpal Pharmaceuticals Limited 323.46 Million INR 95.982%
J. B. Chemicals & Pharmaceuticals Limited 9.33 Billion INR 99.861%
Jubilant Pharmova Limited 8 Billion INR 99.838%
Kilitch Drugs (India) Limited 287.42 Million INR 95.478%
Medicamen Biotech Limited 245.66 Million INR 94.71%
Medico Remedies Limited 129.09 Million INR 89.933%
Wockhardt Limited 1.08 Billion INR 98.797%
Orchid Pharma Limited 1.41 Billion INR 99.084%
RPG Life Sciences Limited 1.28 Billion INR 98.986%
Shilpa Medicare Limited 2.58 Billion INR 99.498%
Sigachi Industries Limited 883.39 Million INR 98.529%
Solara Active Pharma Sciences Limited -2.82 Billion INR 100.461%
Unichem Laboratories Limited 742.35 Million INR 98.249%
Vaishali Pharma Limited 31.71 Million INR 59.017%
Wanbury Limited 985.49 Million INR 98.681%
Zydus Lifesciences Limited 56.22 Billion INR 99.977%
FDC Limited 3.38 Billion INR 99.616%
Amrutanjan Health Care Limited 681.59 Million INR 98.093%
Bajaj HealthCare Limited 406.23 Million INR 96.801%
Dr. Reddy's Laboratories Limited 88.27 Billion INR 99.985%
Glenmark Life Sciences Limited 6.86 Billion INR 99.811%
Ind-Swift Laboratories Limited 6.86 Billion INR 99.811%
Laurus Labs Limited 8 Billion INR 99.838%
Mangalam Drugs & Organics Limited 174.94 Million INR 92.571%
Nectar Lifesciences Limited 1.53 Billion INR 99.154%
Par Drugs and Chemicals Limited 228.17 Million INR 94.304%
Hester Biosciences Limited 539.47 Million INR 97.591%
Ipca Laboratories Limited 13.29 Billion INR 99.902%
Venus Remedies Limited 711.8 Million INR 98.174%
ZIM Laboratories Limited 462.09 Million INR 97.188%
Aurobindo Pharma Limited 61.78 Billion INR 99.979%
Morepen Laboratories Limited 1.72 Billion INR 99.247%
Neuland Laboratories Limited 4.74 Billion INR 99.726%
Sequent Scientific Limited 549.8 Million INR 97.636%
Suven Pharmaceuticals Limited 4.67 Billion INR 99.722%
Valiant Laboratories Limited 12.73 Million INR -2.017%
Windlas Biotech Limited 781.72 Million INR 98.338%
Hikal Limited 2.69 Billion INR 99.517%
Innova Captab Limited 1.66 Billion INR 99.221%
Procter & Gamble Health Limited 3.07 Billion INR 99.577%
Themis Medicare Limited 562.6 Million INR 97.69%
IOL Chemicals and Pharmaceuticals Limited 2.6 Billion INR 99.501%
Mankind Pharma Limited 28.09 Billion INR 99.954%
Glenmark Pharmaceuticals Limited 11.34 Billion INR 99.885%
Sakar Healthcare Limited 393.26 Million INR 96.695%
Albert David Limited 1.04 Billion INR 98.757%
Lupin Limited 36.96 Billion INR 99.965%
Gufic Biosciences Limited 1.48 Billion INR 99.122%
Sun Pharmaceutical Industries Limited 138.36 Billion INR 99.991%
Lincoln Pharmaceuticals Limited 1.34 Billion INR 99.033%
Syncom Formulations (India) Limited 430.27 Million INR 96.98%
Piramal Enterprises Limited -3.86 Billion INR 100.337%
Torrent Pharmaceuticals Limited 35 Billion INR 99.963%
NATCO Pharma Limited 18.79 Billion INR 99.931%
Suven Life Sciences Limited -992.78 Million INR 101.309%
Krebs Biochemicals & Industries Limited -82.72 Million INR 115.71%
Strides Pharma Science Limited 3.76 Billion INR 99.655%
Indoco Remedies Limited 2.64 Billion INR 99.509%
Alpa Laboratories Limited 229.96 Million INR 94.349%
Lasa Supergenerics Limited -65.08 Million INR 119.969%
Sun Pharma Advanced Research Company Limited -3.73 Billion INR 100.348%